Literature DB >> 1801537

Oxidative stress as a cause of Parkinson's disease.

P Jenner1.   

Abstract

The cause of dopamine cell death in Parkinson's disease remains unknown. Present interest centres on the possible involvement of a toxin mediated mechanism such as that produced, by MPTP. In post-mortem studies there is evidence in the substantia nigra for an on-going toxic process involving increased lipid peroxidation, altered iron metabolism and impairment of mitochondrial function at the level of complex I. Although the precise relationship between these biochemical changes is not known, present evidence points to oxidative stress as an important factor contributing to neuronal loss. Altered mitochondrial function and increased iron levels may not initiate Parkinson's disease but rather act to accelerate cell death. Future strategies for the treatment of Parkinson's disease should be aimed at preventing oxidative stress and stopping or slowing the progression of the underlying pathology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801537     DOI: 10.1111/j.1600-0404.1991.tb05013.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  30 in total

Review 1.  Potential role of cannabinoids in Parkinson's disease.

Authors:  J Sevcík; K Masek
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

3.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

4.  Uptake of 75-Selenium into the central nervous system of the rat.

Authors:  R G Pullen; M Schofield; A Markham; J Lough; K Menton
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

5.  Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.

Authors:  R M Wu; D L Murphy; C C Chiueh
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser422 and Formation of Misfolded Protein Aggregates.

Authors:  John C Means; Adam A Lopez; Peter Koulen
Journal:  Cell Mol Neurobiol       Date:  2020-01-09       Impact factor: 5.046

Review 7.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

8.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

9.  Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide.

Authors:  Zhenquan Jia; Hong Zhu; Hara P Misra; Yunbo Li
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

Review 10.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.